- Nonmotor Symptoms and Subthalamic Deep Brain Stimulation in Parkinson’s Disease
-
Han-Joon Kim, Beom S. Jeon, Sun Ha Paek
-
J Mov Disord. 2015;8(2):83-91. Published online May 31, 2015
-
DOI: https://doi.org/10.14802/jmd.15010
-
-
23,316
View
-
234
Download
-
41
Citations
-
Abstract
PDF
- Subthalamic deep brain stimulation (STN DBS) is an established treatment for the motor symptoms in patients with advanced Parkinson’s disease (PD). In addition to improvements in motor symptoms, many studies have reported changes in various nonmotor symptoms (NMSs) after STN DBS in patients with PD. Psychiatric symptoms, including depression, apathy, anxiety, and impulsivity, can worsen or improve depending on the electrical stimulation parameters, the locations of the stimulating contacts within the STN, and changes in medications after surgery. Global cognitive function is not affected by STN DBS, and there is no increase in the incidence of dementia after STN DBS compared to that after medical treatment, although clinically insignificant declines in verbal fluency have been consistently reported. Pain, especially PD-related pain, improves with STN DBS. Evidence regarding the effects of STN DBS on autonomic symptoms and sleep-related problems is limited and remains conflicting. Many symptoms of nonmotor fluctuations, which are occasionally more troublesome than motor fluctuations, improve with STN DBS. Although it is clear that NMSs are not target symptoms for STN DBS, NMSs have a strong influence on the quality of life of patients with PD, and clinicians should thus be aware of these NMSs when deciding whether to perform surgery and should pay attention to changes in these symptoms after STN DBS to ensure the optimal care for patients.
-
Citations
Citations to this article as recorded by 
- A Wellness Prescription for Parkinson's: Mid to Late-stage Disease
Gregory M Pontone, Bradley McDaniels, Adrienne M Keener, Indu Subramanian The American Journal of Geriatric Psychiatry.2023;[Epub] CrossRef - Subthalamic Nucleus Stimulation in Parkinson's Disease: 5‐Year Extension Study of a Randomized Trial
Silje Bjerknes, Mathias Toft, Reidun Brandt, Trine Waage Rygvold, Ane Konglund, Espen Dietrichs, Stein Andersson, Inger Marie Skogseid Movement Disorders Clinical Practice.2022; 9(1): 48. CrossRef - Effects of subthalamic deep brain stimulation on non‐motor symptoms of Parkinson's disease: A meta‐analysis
Zahra Eghlidos, Zahra Rahimian, Gholamreza Vadiee, Soodeh Jahangiri Acta Neurologica Scandinavica.2022; 146(2): 115. CrossRef - Nomogram for Predicting Depression Improvement after Deep Brain Stimulation for Parkinson’s Disease
Bowen Chang, Chen Ni, Jiaming Mei, Chi Xiong, Peng Chen, Manli Jiang, Chaoshi Niu Brain Sciences.2022; 12(7): 841. CrossRef - A nigra–subthalamic circuit is involved in acute and chronic pain states
Cui Yin, Tao Jia, Yiwen Luan, Xue Zhang, Cheng Xiao, Chunyi Zhou Pain.2022; 163(10): 1952. CrossRef - A nigro–subthalamo–parabrachial pathway modulates pain-like behaviors
Tao Jia, Ying-Di Wang, Jing Chen, Xue Zhang, Jun-Li Cao, Cheng Xiao, Chunyi Zhou Nature Communications.2022;[Epub] CrossRef - Basal impulses: findings from the last twenty years on impulsivity and reward pathways using deep brain stimulation
Pavan S. UPADHYAYULA, Robert C. RENNERT, Joel R. MARTIN, John K. YUE, Jason YANG, Eva M. GILLIS-BUCK, Nikki SIDHU, Christopher K. CHEUNG, Anthony T. LEE, Reid R. HOSHIDE, Joseph D. CIACCI Journal of Neurosurgical Sciences.2021;[Epub] CrossRef - Pallidal versus subthalamic deep-brain stimulation for meige syndrome: a retrospective study
Jiayu Liu, Hu Ding, Ke Xu, Ruen Liu, Dongliang Wang, Jia Ouyang, Zhi Liu, Zeyu Miao Scientific Reports.2021;[Epub] CrossRef - Eight‐year follow‐up outcome of subthalamic deep brain stimulation for Parkinson’s disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity
Lulu Jiang, Wanru Chen, Qiyu Guo, Chao Yang, Jing Gu, Wenbiao Xian, Yanmei Liu, Yifan Zheng, Jing Ye, Shaohua Xu, Yu Hu, Lei Wu, Jie Chen, Hao Qian, Xiaoli Fu, Jinlong Liu, Ling Chen CNS Neuroscience & Therapeutics.2021; 27(11): 1366. CrossRef - Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease
Gabriele Bellini, Laura A. Best, Una Brechany, Russell Mills, Nicola Pavese Movement Disorders Clinical Practice.2020; 7(4): 373. CrossRef - Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice
Yiwen Luan, Dongliang Tang, Haichuan Wu, Weixin Gu, Yuqing Wu, Jun-Li Cao, Cheng Xiao, Chunyi Zhou Proceedings of the National Academy of Sciences.2020; 117(18): 10045. CrossRef - Impulsivity and Compulsivity After Subthalamic Deep Brain Stimulation for Parkinson’s Disease
Sara Scherrer, Andrew H. Smith, Jaimie Gowatsky, Christina A. Palmese, Joohi Jimenez-Shahed, Brian H. Kopell, Helen S. Mayberg, Martijn Figee Frontiers in Behavioral Neuroscience.2020;[Epub] CrossRef - Deep brain stimulation and recordings: Insights into the contributions of subthalamic nucleus in cognition
Neil M. Drummond, Robert Chen NeuroImage.2020; 222: 117300. CrossRef - Bilateral Subthalamic Nucleus Deep Brain Stimulation under General Anesthesia: Literature Review and Single Center Experience
Hye Ran Park, Yong Hoon Lim, Eun Jin Song, Jae Meen Lee, Kawngwoo Park, Kwang Hyon Park, Woong-Woo Lee, Han-Joon Kim, Beomseok Jeon, Sun Ha Paek Journal of Clinical Medicine.2020; 9(9): 3044. CrossRef - Subthalamic deep brain stimulation improves sleep and excessive sweating in Parkinson’s disease
Silje Bjerknes, Inger Marie Skogseid, Tuva Jin Hauge, Espen Dietrichs, Mathias Toft npj Parkinson's Disease.2020;[Epub] CrossRef - Impacto de la estimulación subtalámica a largo plazo sobre la situación cognitiva de los pacientes con enfermedad de Parkinson avanzada
M. Acera, A. Molano, B. Tijero, G. Bilbao, I. Lambarri, R. Villoria, J. Somme, E. Ruiz de Gopegui, I. Gabilondo, J.C. Gomez-Esteban Neurología.2019; 34(9): 573. CrossRef - The Subthalamic Nucleus: Unravelling New Roles and Mechanisms in the Control of Action
Tora Bonnevie, Kareem A. Zaghloul The Neuroscientist.2019; 25(1): 48. CrossRef - Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease
U. Hidding, A. Gulberti, C. Pflug, C. Choe, A. Horn, L. Prilop, H. Braaß, O. Fründt, C. Buhmann, D. Weiss, M. Westphal, A.K. Engel, C. Gerloff, J.A. Köppen, W. Hamel, C.K.E. Moll, M. Pötter-Nerger Parkinsonism & Related Disorders.2019; 62: 141. CrossRef - Zona incerta GABAergic neurons integrate prey-related sensory signals and induce an appetitive drive to promote hunting
Zheng-dong Zhao, Zongming Chen, Xinkuan Xiang, Mengna Hu, Hengchang Xie, Xiaoning Jia, Fang Cai, Yuting Cui, Zijun Chen, Lechen Qian, Jiashu Liu, Congping Shang, Yiqing Yang, Xinyan Ni, Wenzhi Sun, Ji Hu, Peng Cao, Haohong Li, Wei L. Shen Nature Neuroscience.2019; 22(6): 921. CrossRef - Long-term impact of subthalamic stimulation on cognitive function in patients with advanced Parkinson's disease
M. Acera, A. Molano, B. Tijero, G. Bilbao, I. Lambarri, R. Villoria, J. Somme, E. Ruiz de Gopegui, I. Gabilondo, J.C. Gomez-Esteban Neurología (English Edition).2019; 34(9): 573. CrossRef - Influencia de la estimulación cerebral profunda en la carga de cuidadores de pacientes con enfermedad de Parkinson
J.A. Crespo-Burillo, D. Rivero-Celada, A. Saenz-de Cabezón, J. Casado-Pellejero, J. Alberdi-Viñas, R. Alarcia-Alejos Neurología.2018; 33(3): 154. CrossRef - Alteration in the Local and Global Functional Connectivity of Resting State Networks in Parkinson’s Disease
Maryam Ghahremani, Jaejun Yoo, Sun Ju Chung, Kwangsun Yoo, Jong C. Ye, Yong Jeong Journal of Movement Disorders.2018; 11(1): 13. CrossRef - Deep brain stimulation for patients with Parkinson's disease: Effect on caregiver burden
J.A. Crespo-Burillo, D. Rivero-Celada, A. Saenz-de Cabezón, J. Casado-Pellejero, J. Alberdi-Viñas, R. Alarcia-Alejos Neurología (English Edition).2018; 33(3): 154. CrossRef - Clinical Markers of Anxiety Subtypes in Parkinson Disease
Martinus P. G. Broen, A. F. G. Leentjens, J. T. Hinkle, A. J. H. Moonen, M. L. Kuijf, N. M. Fischer, K. Perepezko, A. Bakker, G. M. Pontone Journal of Geriatric Psychiatry and Neurology.2018; 31(2): 55. CrossRef - Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus in Parkinson’s Disease: A Meta-Analysis
Ying Wang, Yongsheng Li, Xiaona Zhang, Anmu Xie Parkinson's Disease.2018; 2018: 1. CrossRef - Non-motor Characterization of the Basal Ganglia: Evidence From Human and Non-human Primate Electrophysiology
Robert S. Eisinger, Morgan E. Urdaneta, Kelly D. Foote, Michael S. Okun, Aysegul Gunduz Frontiers in Neuroscience.2018;[Epub] CrossRef - Revealing a novel nociceptive network that links the subthalamic nucleus to pain processing
Arnaud Pautrat, Marta Rolland, Margaux Barthelemy, Christelle Baunez, Valérie Sinniger, Brigitte Piallat, Marc Savasta, Paul G Overton, Olivier David, Veronique Coizet eLife.2018;[Epub] CrossRef - Cerebrospinal fluid protein markers in PD patients after DBS-STN surgery—A retrospective analysis of patients that underwent surgery between 1993 and 2001
Radu Constantinescu, Kaj Blennow, Lars Rosengren, Barbro Eriksson, Thordis Gudmundsdottir, Yvonne Jansson, Bo Johnels, Annika Renck, Filip Bergquist Clinical Neurology and Neurosurgery.2018; 174: 174. CrossRef - Predictors to quality of life improvements after subthalamic stimulation in Parkinson’s disease
Feng‐Tao Liu, Li‐Qin Lang, Yu‐Jie Yang, Jue Zhao, Rui Feng, Jie Hu, Jian Wang, Jian‐Jun Wu Acta Neurologica Scandinavica.2018;[Epub] CrossRef - Apathy associated with neurocognitive disorders: Recent progress and future directions
Krista L. Lanctôt, Luis Agüera‐Ortiz, Henry Brodaty, Paul T. Francis, Yonas E. Geda, Zahinoor Ismail, Gad A. Marshall, Moyra E. Mortby, Chiadi U. Onyike, Prasad R. Padala, Antonios M. Politis, Paul B. Rosenberg, Emma Siegel, David L. Sultzer, Eleenor H. A Alzheimer's & Dementia.2017; 13(1): 84. CrossRef - Can deep brain stimulation be a therapeutic option for Parkinson's disease dementia?
Han‐Joon Kim, Beomseok Jeon, Jee‐Young Lee, Sun Ha Paek Neurology and Clinical Neuroscience.2017; 5(1): 3. CrossRef - The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence
Mónica M Kurtis, Thadshani Rajah, Luisa F Delgado, Haidar S Dafsari npj Parkinson's Disease.2017;[Epub] CrossRef - Delayed responses of subthalamic nucleus to deep brain stimulation in patients with Parkinson's disease
Lin Shi, Kai Zhang, Fan-Gang Meng, Guan-Yu Zhu, Ying-Chuan Chen, Jun-Jian Zhou, Zhong-Hai Zhou, Jian-Guo Zhang Parkinsonism & Related Disorders.2017; 40: 76. CrossRef - Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease
Margherita Fabbri, Miguel Coelho, Leonor Correia Guedes, Mario M. Rosa, Daisy Abreu, Nilza Gonçalves, Angelo Antonini, Joaquim J. Ferreira Parkinsonism & Related Disorders.2017;[Epub] CrossRef - Deep Brain Stimulation of Hemiparkinsonian Rats with Unipolar and Bipolar Electrodes for up to 6 Weeks: Behavioral Testing of Freely Moving Animals
Kathrin Badstuebner, Ulrike Gimsa, Immo Weber, Armin Tuchscherer, Jan Gimsa Parkinson's Disease.2017; 2017: 1. CrossRef - Current Topics in Deep Brain Stimulation for Parkinson Disease
Atsushi UMEMURA, Genko OYAMA, Yasushi SHIMO, Madoka NAKAJIMA, Asuka NAKAJIMA, Takayuki JO, Satoko SEKIMOTO, Masanobu ITO, Takumi MITSUHASHI, Nobutaka HATTORI, Hajime ARAI Neurologia medico-chirurgica.2016; 56(10): 613. CrossRef - In Parkinson’s disease STN stimulation enhances responsiveness of movement initiation speed to high reward value
Maja Kojovic, Andrea Higgins, Marjan Jahanshahi Neuropsychologia.2016; 89: 273. CrossRef - Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson’s Disease
Lei-Fang Cao, Xiao-Yan Peng, Ya Huang, Bing Wang, Feng-Ming Zhou, Ruo-Xiao Cheng, Li-Hua Chen, Wei-Feng Luo, Tong Liu Neural Plasticity.2016; 2016: 1. CrossRef - The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group
Do-Young Kwon, Seong-Beom Koh, Jae Hyeok Lee, Hee Kyung Park, Han-Joon Kim, Hae-Won Shin, Jinyoung Youn, Kun Woo Park, Sun-Ah Choi, Sang Jin Kim, Seong-Min Choi, Ji-Yun Park, Beom S. Jeon, Ji Young Kim, Sun Ju Chung, Chong Sik Lee, Jeong-Ho Park, Tae-Beom Journal of Clinical Neurology.2016; 12(4): 393. CrossRef - Antiparkinsonian Treatment for Depression in Parkinson's Disease: Are Selective Serotonin Reuptake Inhibitors Recommended?
Philippe De Deurwaerdère, Yuqiang Ding Translational Neuroscience and Clinics.2016; 2(2): 138. CrossRef - The Subthalamic Nucleus, Limbic Function, and Impulse Control
P. Justin Rossi, Aysegul Gunduz, Michael S. Okun Neuropsychology Review.2015; 25(4): 398. CrossRef
- Stiff-Person Syndrome: Case Series
-
Yu Jin Jung, Han G. Jeong, Ryul Kim, Han-Joon Kim, Beom S. Jeon
-
J Mov Disord. 2014;7(1):19-21. Published online April 30, 2014
-
DOI: https://doi.org/10.14802/jmd.14004
-
-
12,695
View
-
1,364
Download
-
4
Citations
-
Abstract
PDF
- Stiff-person syndrome (SPS) is a rare disorder, characterized by progressive fluctuating muscular rigidity and spasms. Glutamic acid decarboxylase (GAD) antibody is primarily involved in the pathogenesis of SPS and SPS is strongly associated with other autoimmune disease. Here we report three cases of patients with classical SPS finally confirmed by high serum level of GAD antibodies. All of our patients respond favorably to gamma amino butyric acid-enhancing drugs and immunotherapies.
-
Citations
Citations to this article as recorded by 
- Stiff Person Syndrome in a patient with atypical carcinoid tumor of the lung secondary to anti-amphiphysin antibodies: A case report and literature review
Khawla Abusamra, Mangayarkarasi Thandampallayam, Douglas Lukins, Padmaja Sudhakar Neuroimmunology Reports.2022; 2: 100116. CrossRef - Efficacy and safety of therapeutic plasma exchange in stiff person syndrome
Piotr F. Czempik, Justyna Gawryluk, Agnieszka Wiórek, Ewa Krzystanek, Łukasz J. Krzych Open Medicine.2021; 16(1): 526. CrossRef - The computational neurology of movement under active inference
Thomas Parr, Jakub Limanowski, Vishal Rawji, Karl Friston Brain.2021; 144(6): 1799. CrossRef - Neuronal Antibodies and Associated Syndromes
Borros M. Arneth Autoimmune Diseases.2019; 2019: 1. CrossRef
- Amantadine Induced Corneal Edema in a Patient with Primary Progressive Freezing of Gait
-
Young Eun Kim, Ji Young Yun, Hui-Jun Yang, Han-Joon Kim, Mee Kum Kim, Won Ryang Wee, Beom S. Jeon
-
J Mov Disord. 2013;6(2):34-36. Published online October 30, 2013
-
DOI: https://doi.org/10.14802/jmd.13008
-
-
17,257
View
-
62
Download
-
6
Citations
-
Abstract
PDF
Amantadine is commonly used for Parkinsonism. However amantadine can induce adverse corneal reaction. Here we report a patient with primary progressive freezing of gait who had severe corneal edema associated with amantadine, which was reversible after discontinuation of the amantadine. This report alerts neurologists for this reversible but potentially critical corneal edema in patients with Parkinsonism who are receiving amantadine.
-
Citations
Citations to this article as recorded by 
- Experience of diagnosis and managements for patients with primary progressive freezing of gait
Li-Li Zhang, Ya-Jie Zhao, Liang Zhang, Xiao-Ping Wang Journal of Neurorestoratology.2022; : 100039. CrossRef - Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells
Po-Yen Lee, Yu-Hung Lai, Po-Len Liu, Ching-Chih Liu, Chia-Cheng Su, Fang-Yen Chiu, Wei-Chung Cheng, Shiuh-Liang Hsu, Kai-Chun Cheng, Li-Yi Chiu, Tzu-En Kao, Chia-Ching Lin, Yo-Chen Chang, Shu-Chi Wang, Chia-Yang Li Scientific Reports.2021;[Epub] CrossRef - Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia
Santiago Perez-Lloret, Olivier Rascol Journal of Neural Transmission.2018; 125(8): 1237. CrossRef - Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked
Merel S. Ekker, Sabine Janssen, Klaus Seppi, Werner Poewe, Nienke M. de Vries, Thomas Theelen, Jorik Nonnekes, Bastiaan R. Bloem Parkinsonism & Related Disorders.2017; 40: 1. CrossRef - Parkinson’s disease between internal medicine and neurology
Ilona Csoti, Wolfgang H. Jost, Heinz Reichmann Journal of Neural Transmission.2016; 123(1): 3. CrossRef - Amantadine Use as a Risk Factor for Corneal Edema: A Nationwide Cohort Study in Taiwan
Po Yen Lee, Hung Pin Tu, Chang Ping Lin, Cheng Hsien Chang, Kai Chun Cheng, Chia Ching Lin, Shiuh Liang Hsu American Journal of Ophthalmology.2016; 171: 122. CrossRef
- Hypomania Induced by Subthalamic Nucleus Stimulation in a Parkinson’s Disease Patient: Does It Suggest a Dysfunction of the Limbic Circuit?
-
Ji Seon Kim, Hee Jin Kim, Ji-Young Lee, Jong Min Kim, Ji Young Yun, Beom S. Jeon
-
J Mov Disord. 2012;5(1):14-17.
-
DOI: https://doi.org/10.14802/jmd.12004
-
-
11,892
View
-
62
Download
-
6
Citations
-
Abstract
PDF
The aim of this report was to describe a case of hypomania after deep brain stimulation of the subthalamic nucleus (STN DBS) in a Parkinson’s disease (PD) patient. 59-year-old man with a 15-year history of PD underwent bilateral implantation of electrodes to the STN. Immediately after surgery, his motor function was markedly improved and his mood was elevated to hypomania. Fusion images of the preoperative MRI and postoperative CT scan showed that the electrodes were located in the medial portion of the STN. In this case, behavioral mood change was related to the deep brain stimulation. Moreover, the anatomical location and the functional alteration of the STN after the DBS surgery might be related to the regulatory system of the associative and limbic cortico-subcortical circuits.
-
Citations
Citations to this article as recorded by 
- Treating addiction with deep brain stimulation: Ethical and legal considerations
Clara Lo, Mansee Mane, Jee Hyun Kim, Michael Berk, Richard R. Sharp, Kendall H. Lee, Jason Yuen International Journal of Drug Policy.2023; 113: 103964. CrossRef - The anatomo-functional organization of the hyperdirect cortical pathway to the subthalamic area using in vivo structural connectivity imaging in humans
Gizem Temiz, Sophie B. Sébille, Chantal Francois, Eric Bardinet, Carine Karachi Brain Structure and Function.2020; 225(2): 551. CrossRef - Hypomania and saccadic changes in Parkinson’s disease: influence of D2 and D3 dopaminergic signalling
Esther A. Pelzer, Barbara Dillenburger, Sophie Grundmann, Vladimir Iliaev, Sophie Aschenberg, Corina Melzer, Martin Hess, Gereon R. Fink, Carsten Eggers, Marc Tittgemeyer, Lars Timmermann npj Parkinson's Disease.2020;[Epub] CrossRef - Overlapping and distinct neural metabolic patterns related to impulsivity and hypomania in Parkinson’s disease
Frank Schwartz, Masoud Tahmasian, Franziska Maier, Luisa Rochhausen, Kim L. Schnorrenberg, Fateme Samea, Joseph Seemiller, Mojtaba Zarei, Christian Sorg, Alexander Drzezga, Lars Timmermann, Thomas D. Meyer, Thilo van Eimeren, Carsten Eggers Brain Imaging and Behavior.2019; 13(1): 241. CrossRef - Affective modulation of the associative-limbic subthalamic nucleus: deep brain stimulation in obsessive–compulsive disorder
Mircea Polosan, Fabien Droux, Astrid Kibleur, Stephan Chabardes, Thierry Bougerol, Olivier David, Paul Krack, Valerie Voon Translational Psychiatry.2019;[Epub] CrossRef - Beyond Emotions: Oscillations of the Amygdala and Their Implications for Electrical Neuromodulation
Lisa-Maria Schönfeld, Lars Wojtecki Frontiers in Neuroscience.2019;[Epub] CrossRef
- Adult Onset Familial Cherry-Red Spot Myoclonus
-
Chi Kyung Kim, Beom S. Jeon
-
J Mov Disord. 2009;2(1):50-52.
-
DOI: https://doi.org/10.14802/jmd.09014
-
-
Abstract
PDF
We report a case of a 36-year-old woman with progressive generalized myoclonus that first became apparent 9 years ago. Her younger brother had similar problems. Examination of her eyes revealed cherry-red spots. Hexosaminidase A, β-galactosidase and neuraminidase activity were normal. Although the laboratory findings were negative, cherry-red spots, progressive myoclonus and autosomal recessive inheritance pattern suggested that she had an unknown type of lysosomal storage disease.
|